Nectar Lifescience Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 430.77 | 455.56 | 428.79 |
| Operating Expense | 585 | 410.27 | 384.76 |
| Net Profit | -130.09 | 7.84 | 5.60 |
| Net Profit Margin | -30.20 | 1.72 | 1.31 |
| Earning Per Share | -5.80 | 0.35 | 0.25 |
| EBIDTA | -96.65 | 40.57 | 40.96 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 430.77 |
| Operating Expense | 585.00 |
| Net Profit | -130.09 |
| Net Profit Margin | -30.20 |
| Earning Per Share | -5.80 |
| EBIDTA | -96.65 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,684.09 | 1,523.67 | 1,668.23 |
| Operating Expenses Annual | 1,532.53 | 1,468.95 | 1,509.42 |
| Operating Profit Annual | 166.14 | 97.90 | 170.13 |
| Interest Annual | 87.14 | 79.48 | 78.81 |
| Depreciation | 60.72 | 59.12 | 56.97 |
| Net Profit Annual | 5.00 | -22.46 | 25.32 |
| Tax Annual | 13.27 | -18.24 | 9.03 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,684.09 |
| Operating Expenses Annual | 1,532.53 |
| Operating Profit Annual | 166.14 |
| Interest Annual | 87.14 |
| Depreciation | 60.72 |
| Net Profit Annual | 5.00 |
| Tax Annual | 13.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 17.57 | 17.74 | 25.43 |
| Cash Flow from Operations | 224.69 | 133.37 | 95.04 |
| Cash Flow from Investing | -17.03 | 52.03 | 16.64 |
| Cash Flow from Financing | -205.44 | -185.57 | -119.38 |
| Cash Flow at the End | 19.80 | 17.57 | 17.74 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 17.57 |
| Cash Flow from Operations | 224.69 |
| Cash Flow from Investing | -17.03 |
| Cash Flow from Financing | -205.44 |
| Cash Flow at the End | 19.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 8.63 | 3.29 | 8.35 |
| PBIT Margin (%) | 5.47 | -0.10 | 5.39 |
| PBT Margin (%) | 5.41 | -0.10 | 5.32 |
| Net PROFIT Margin (%) | 0.26 | -1.29 | 1.32 |
| Return On Networth / Equity (%) | 0.47 | -5.85 | 1.48 |
| Return On Networth /Employed (%) | 5.96 | -0.09 | 5.28 |
| Return On Assets (%) | 0.28 | -1.18 | 1.29 |
| Total Debt / Equity (X) | 0.65 | 0.75 | 0.82 |
| Asset Turnover Ratio (%) | 1.09 | 0.92 | 0.98 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 8.63 |
| PBIT Margin (%) | 5.47 |
| PBT Margin (%) | 5.41 |
| Net PROFIT Margin (%) | 0.26 |
| Return On Networth / Equity (%) | 0.47 |
| Return On Networth /Employed (%) | 5.96 |
| Return On Assets (%) | 0.28 |
| Total Debt / Equity (X) | 0.65 |
| Asset Turnover Ratio (%) | 1.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 642.71 | 661.97 | 723.10 |
| Total Current Assets Annual | 1,283.83 | 1,231.17 | 1,353.75 |
| Non Current Assets Annual | 907.23 | 958.04 | 1,035.95 |
| Total Shareholders Funds Annual | 1,069.25 | 1,064.60 | 1,086.86 |
| Total Assets Annual | 2,191.06 | 2,189.21 | 2,389.71 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 642.71 |
| Total Current Assets Annual | 1,283.83 |
| Non Current Assets Annual | 907.23 |
| Total Shareholders Funds Annual | 1,069.25 |
| Total Assets Annual | 2,191.06 |
EPS (INR)
Expected
0.00
Reported
-5.80
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
